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Abstract
Levels of expression of the transcription factor Pax6 vary throughout corticogenesis in a rostro-
lateralhigh to caudo-mediallow gradient across the cortical proliferative zone. Previous loss-of-
function studies have indicated that Pax6 is required for normal cortical progenitor proliferation,
neuronal differentiation, cortical lamination and cortical arealization, but whether and how its
level of expression affects its function is unclear. We studied the developing cortex of PAX77
YAC transgenic mice carrying several copies of the human PAX6 locus with its full complement
of regulatory regions. We found that PAX77 embryos express Pax6 in a normal spatial pattern,
with levels up to three times higher than wild type. By crossing PAX77 mice with a new YAC
transgenic line that reports Pax6 expression (DTy54), we showed that increased expression is
limited by negative autoregulation. Increased expression reduces proliferation of late cortical
progenitors specifically, and analysis of PAX77↔wild-type chimeras indicates that the defect is
cell autonomous. We analyzed cortical arealization in PAX77 mice and found that, whereas the
loss of Pax6 shifts caudal cortical areas rostrally, Pax6 overexpression at levels predicted to shift
rostral areas caudally has very little effect. These findings indicate that Pax6 levels are stabilized
by autoregulation, that the proliferation of cortical progenitors is sensitive to altered Pax6 levels
and that cortical arealization is not.
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INTRODUCTION
The complexity of brain structure and function is established through the generation of
numerous and frequently subtle differences among progenitor cells and the neurons that they
produce. Molecular differences between cells in the embryonic nervous system are
detectable from its inception and arise as cells are exposed to different levels of morphogens
released by surrounding signalling centres. These morphogens determine the levels of
expression of key transcription factors that pattern the nervous system, creating domains that
express characteristic combinations of transcription factors specifying their morphologies
and functions (Kerszberg, 1999; Neumann and Cohen, 1997; Tabata and Takei, 2004; Yucel
and Small, 2006). The potential of a limited set of transcription factors to direct the
generation of an enormous diversity of neuronal phenotypes might be enhanced greatly if
different levels of transcription factors cause different developmental outcomes. If levels of
expression are important, then two predictions can be made: (i) developing neurons should
contain mechanisms to stabilize levels of expression of transcription factors in the face of
altering exposure to environmental signals as the embryo grows and changes; and (ii)
neurogenesis should be affected if levels of transcription factor expression are altered. Here,
we tested these predictions for the transcription factor Pax6.
Mice homozygous for a loss-of-function mutation of Pax6 lack eyes and nasal structures,
and die at birth with serious brain abnormalities, including forebrain patterning and growth
defects (Bishop et al., 2000; Bishop et al., 2002; Estivill-Torrus et al., 2002; Grindley et al.,
1997; Hill et al., 1991; Hogan et al., 1986; Kroll and O’Leary, 2005; Mastick et al., 1997;
Muzio et al., 2002; Pratt et al., 2000; Schmahl et al., 1993; Stoykova et al., 1996; Warren
and Price, 1997). In normal mice, corticogenesis occurs from E10.5 to E17.5 by a process of
progenitor proliferation in the ventricular zone (VZ) followed by migration of neural
precursors to the overlying cortical plate. Pax6 is expressed in the VZ throughout
corticogenesis (Caric et al., 1997; Estivill-Torrus et al., 2002; Walther and Gruss, 1991) and
is implicated in progenitor proliferation, migration, differentiation, lamination and
arealization (Bishop et al., 2000; Estivill-Torrus et al., 2002; Heins et al., 2002; Schuurmans
et al., 2004; Tarabykin et al., 2001). Previous studies identified a reduced progenitor
population and defective differentiation as primary defects resulting from the loss of Pax6
(Heins et al., 2002; Quinn et al., 2006).
Most studies on the functions of Pax6 in brain development have studied the consequences
of its removal. Whether the level at which it is expressed in the brain is important is unclear,
although its expression in a gradient in the cortex suggests that it might be. Levels of
expression in the eye are crucial, with both reduced and increased gene dosage causing
defects in development (Schedl et al., 1996). Here, we tested whether increased levels of
Pax6 affect cortical progenitor proliferation, cortical lamination and cortical arealization
using the PAX77 mouse line produced by Schedl et al. (Schedl et al., 1996). In addition to
their two endogenous Pax6 alleles, mice hemizygous for the PAX77 transgene carry five to
seven copies of the human PAX6 locus, including its upstream and downstream regulatory
regions (the mouse and human Pax6 proteins are identical). The PAX77 transgene is
functional, as demonstrated by its ability to rescue the eye and brain defects in mice carrying
loss-of-function mutations of Pax6 (Schedl et al., 1996).
MATERIALS AND METHODS
Mice
PAX77 hemizygous mice (Schedl et al., 1996), designated PAX77+, carry five to seven
copies of a 420 kb human PAX6 YAC (Y593) with all copies integrated at the same locus.
We refer to the array of integrated YAC Y593 copies as the PAX77 transgene. PAX77
Manuel et al. Page 2
Development. Author manuscript; available in PMC 2008 May 16.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
homozygous mice, designated PAX77+/+, carry 10-14 copies of human PAX6 and were
genotyped by fluorescent in situ hybridization using the Fat5 probe (Schedl et al., 1996).
The PAX77 line was maintained on a CD1 background. The morning of the vaginal plug
was deemed E0.5. The first 24 hours after birth was deemed P0. Animal care followed
institutional guidelines and UK Home Office regulations.
Western blots
For each protein sample, two E12.5 telencephalons of the same genotype were combined
and lysed in TENT buffer (20 mM Tris-HCl, pH 8.0; 2 mM EDTA; 150 mM NaCl; 1% (v/v)
Triton-X100). Subsequent processing followed Pinson et al. (Pinson et al., 2006), using anti-
Pax6 serum 13 (1:200; from S. Saule, Institut Curie, Paris, France) (Carriere et al., 1993)
and anti b-actin (1:5000; Sigma). Densities of bands on X-ray films were quantified with a
GS-710 densitometer and Quantity One software (BioRad).
Autoregulation of Pax6
We generated reporter transgenic mice containing one copy of a modified version of the
PAX6-containing YAC used to generate the PAX77 line. The modified YAC (Y1123)
contains the upstream and downstream regulatory regions sufficient to recapitulate full
PAX6 expression, but the PAX6 gene is rendered non-functional by the insertion of a tau-
green fluorescent protein (tau-GFP) reporter construct (Tyas et al., 2006). Expression of tau-
GFP from Y1123 in these mice, named DTy54, reports faithfully the sites and levels of
endogenous Pax6 expression (Tyas et al., 2006). Here, we studied the expression from
Y1123 in Pax6+/+, Pax6Sey/Sey (designated Pax6−/−) or PAX77+ embryos. Embryos were
fixed (4% paraformaldehyde) and embedded in 4% low-melting-point agarose. Vibratome
sections (200 μm) were counterstained with TOPRO3 (Molecular Probes, NL) and imaged
(Leica confocal microscope). To prepare isolated cells, heads from E14.5 Pax6+/+, Pax6−/−
or PAX77 embryos also carrying Y1123, or from wild-type embryos were dissociated
(Papain Dissociation System, Worthington Biochemical). Cells were analyzed on a
Beckman-Coulter XL flow cytometer (10,000-20,000 cells per sample).
Quantitative reverse transcription PCR
Telencephalic cDNA samples were collected from E14.5 wild-type or PAX77+ embryos.
Quantitative reverse transcription PCR (qRT-PCR) used the following primer pairs: mouse
Pax6 (5′-AACACCAACTCCATCAGTTC-3′ and 5′-ATCTGGATAATGGGTCCTCT-3′;
153 bp product) and 18S ribosomal RNA (5′-GTGGAGCGATTTGTCTGGTT-3′ and 5′-
CAAGCTTATGACCCGCACTT-3′; 321 bp product). qRT-PCR was performed using
Qiagen Quantitect SYBR Green PCR kit (Qiagen, USA) and a DNA Engine Opticon
Continuous Fluorescence Detector (GRI, UK). The abundance of each transcript in the
original RNA sample was extrapolated from PCR reaction kinetics using Opticon software.
Cortical progenitor proliferation
E12.5 or E15.5 pregnant females were sacrificed 1 hour after injection with 200 μl of 10
mg/ml bromodeoxyuridine (BrdU, Sigma; in 0.9% NaCl, intraperitoneal). Wax sections (10
μm) were immunostained with anti-BrdU or anti-phosphorylated histone H3. Cells were
counted in 100 μm-wide sampling boxes in the VZ and subventricular zone (SVZ) of the
rostral, central and caudal cortex of three wild-type and three PAX77+ embryos. Each count
was repeated on three to five non-adjacent sections from each embryo for BrdU analysis and
on 10-19 non-adjacent sections for phosphorylated histone H3 analysis.
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Cortical layer thickness
A total of three wild-type and three PAX77+ P7 pups were anesthetized and perfused with
4% paraformaldehyde. Coronal wax sections (10 μm) were stained with cresyl violet. For
each brain, the thickness of the cortical layers was measured using the Image Tool software
(University of Texas Health Science Centre at San Antonio, San Antonio, TX, USA) on
16-28 non-adjacent sections at equivalent rostral, central and caudal levels.
Chimeric embryos
Chimeras were produced by embryo aggregation (West and Flockhart, 1994). Embryos
differed at the Gpi1 locus (encoding glucose phosphate isomerase) and one of each pair
carried a reiterated β-globin TgN (Hbb-b1) transgene (abbreviated to Tg), identifiable by
DNA in situ hybridization (Keighren and West, 1993; Lo, 1986; Lo et al., 1987). Outbred
CD1A females (homozygous Gpi1a/a CD1 strain mice) were induced to ovulate and were
mated to hemizygous PAX77+ males on a CD1A background to produce PAX77+ and wild-
type embryos, all of which were Gpi1a/a;Tg−/−. (C57BL/6×CBA/Ca)F1 females (Gpi1b/b;
Tg−/−) were induced to ovulate and were mated to ‘BTC’-strain males (Gpi1b/b;Tg+/+ on a
mixed [C57BL/6×CBA/Ca] background) to produce embryos, all of which were wild-type,
Gpi1b/b; Tg+/−. Chimeras were transferred to pseudopregnant Gpi1c/c (‘CF1’ hybrid strain)
females. E16.5 foetuses were dissected into cold PBS, and their limbs and tails were
removed and analyzed by GPI1 electrophoresis (West and Flockhart, 1994). Heads were
fixed and processed for analysis by in situ hybridization and other body tissues were
digested to obtain DNA for PCR genotyping to distinguish PAX77↔wild-type and wild-
type↔wild-type chimeras. A total of three to five non-consecutive coronal sections from
each chimeric brain were examined for each hemisphere and each region along the anterior-
posterior axis. Percentages of Tg− cells were determined by counting numbers of
hybridization signals and nuclei in 100 μm-wide boxes. The contribution of Gpi1a/a cells to
chimeras used here was 42-86%.
To determine proportions of Tg− and Tg+ cells in M-phase in PAX77↔wild-type chimeras,
β-globin DNA in situ hybridization was followed by immunostaining with anti-
phosphorylated histone H3. Nickel was added to the diaminobenzidine visualization solution
to obtain a grey precipitate. Cells were counted in 100 μm-wide sampling boxes in the VZ
of the rostral cortex of each E16.5 chimeric or wild-type embryo. Each count was repeated
on four to five non-adjacent sections. The contribution of Gpi1a/a cells to the chimeras used
here was 42-57%.
Immunohistochemistry
Processing for Emx2 detection was as described in Mallamaci et al. (Mallamaci et al., 1996),
for Ephrin B2 detection was as in Pratt et al. (Pratt et al., 2004) and for all other
immunochemistry reactions was as in Martynoga et al. (Martynoga et al., 2005).
Immunostaining reactions were performed as in Martynoga et al. (Martynoga et al., 2005),
except that antigen retrieval was not necessary for Emx2 detection. Primary antibodies were
BrdU (1:200; Becton Dickinson), phosphorylated histone H3 (1:500; Sigma), Pax6 (1:500;
DSHB), Emx2 (1:500, a gift from G. Corte, National Institute for Cancer Research, Genova,
Italy) and Ephrin B2 (1:500; R&D Systems AF496,). To analyze the cortical Pax6 gradient,
a biotinylated secondary antibody was used with Alexa Fluor 488-conjugated streptavidin
(Molecular Probes, Inc.). Serial sagittal sections through four cortical hemispheres from
wild-type and PAX77+/+ E12.5 embryos were analyzed (Leica confocal microscope). The
fluorescence intensity was quantified on each section in 50 μm×50 μm boxes placed at
rostral and caudal cortical poles, and the ratio between the two was calculated. The highest
anterior/posterior ratio for each cortical hemisphere was used to give a value for the
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maximum steepness of its Pax6 gradient. An average was calculated from all four
hemispheres.
In situ hybridization
For Id2 in situ hybridization, embryos were dissected (cold PBS), fixed overnight (4%
paraformaldehyde), wax-embedded and sectioned (10 μm). In situ hybridization was
performed (Porteus et al., 1992) using a digoxigenin-labeled anti-sense Id2 RNA probe
(from D. O’Leary, the Salk institute, La Jolla, USA).
Analysis of the cortical barrel field
P7 pups were anesthetized and perfused (4% paraformaldehyde), and cerebral hemispheres
were removed, postfixed between slides and then cryoprotected in 30% sucrose. Tangential
serial 48 μm frozen sections were obtained and immunostained for serotonin transporter
(Watson et al., 2006). Images were captured (Leica DMLB microscope), and linear and area
measurements obtained (Image Tool software).
RESULTS
Pax6 protein levels are increased in PAX77 mice
We compared Pax6 protein levels in wild-type, PAX77+ and PAX77+/+ embryonic brains
using western blots (Fig. 1A,B). The two major isoforms of Pax6 - Pax6 (46 kDa) and
Pax6(5a) (48 kDa) - were significantly upregulated in PAX77+ and PAX77+/+ brains
compared with wild type (Fig. 1B). The increases were not as great as the increases in the
numbers of copies of the gene, and there was no significant difference in the levels of Pax6
and Pax6(5a) between PAX77+ and PAX77+/+ brains (Fig. 1B). We also analyzed Pax6
expression by immunohistochemistry on sections of E12.5 brains (Fig. 1C-E). The levels of
Pax6 appeared higher in both PAX77+ and PAX77+/+ brains than in wild type. The Pax6
expression pattern in PAX77 brains reproduces that in the wild-type brain without any
ectopic sites of expression, and the rostro-lateralhigh to caudo-mediallow gradient of cortical
Pax6 expression is conserved (Fig. 1C-E).
Negative autoregulation of the Pax6 locus
Our finding that Pax6 protein levels do not increase in proportion to gene copy number
suggests that a negative autoregulation of the expression of the gene exists. To test this, we
examined the expression of tau-GFP from one copy of Y1123 (Material and methods) (Tyas
et al., 2006) in embryos that were Pax6+/+, Pax6−/− or PAX77+ with confocal microscope
settings held constant throughout (Fig. 2A-C). The signal was much weaker in the cortex of
PAX77 mice (Fig. 2B), and was more intense in Pax6−/− cortex (Fig. 2C), than in wild-type
cortex. Previous studies of Pax6−/− brains have shown that, although their morphology is
distorted, mutant counterparts of major brain structures are recognizable and Pax6 mRNA
expression is restricted to regions corresponding to Pax6-expressing regions in wild-type
mice (Stoykova et al., 1996; Warren and Price, 1997). We found that, in Pax6−/− brains, the
expression of tau-GFP from Y1123 is also restricted to these regions; Fig. 2C shows
expression limited to dorsal telencephalic cells in mutants, as in wild type (Fig. 2A).
Reduced GFP expression in PAX77 embryos and increased expression in Pax6−/− embryos
was not confined to the forebrain, but was seen in all regions that express Pax6 (see Fig. S1
in the supplementary material).
Results from flow cytometry on dissociated cells from E14.5 brains are shown in Fig. 2D-H.
Data in each histogram in Fig. 2D-G is from a single embryo. Analysis of non-transgenic
embryos provided frequency distributions of background fluorescence intensity (Fig. 2D):
distributions were similar in different individuals and gate B was set to include an average of
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2% of cells (range 1-5%) in a set of 12 samples from non-transgenic embryos. Cells falling
within gate B in Y1123 transgenic embryos (Fig. 2E-G) were considered to express tau-
GFP. Each frequency distribution shown in Fig. 2D-G was similar to that from all the other
embryos of the same genotype (n=4-6 embryos per genotype). For each sample, the average
fluorescence intensity of the population of cells within gate B was obtained and data were
combined for each genotype group (Fig. 2H); combining values for the median fluorescence
intensity of each sample gave the same outcome (data not shown). Embryos of all three
genotypes contained populations of GFP-expressing cells, but the average fluorescence
intensity of this population was higher on a Pax6−/− background (Fig. 2E,F,H) and lower on
a PAX77 background (Fig. 2E,G,H). These results indicate that GFP-expressing cells
increase their expression levels in the absence of Pax6 proteins, whereas an 1.5- to 3-fold
non-ectopic overexpression of Pax6 suppresses GFP expression. We conclude that the level
of activity of the Y1123 reporter is inversely related to the level of endogenous Pax6
production.
We carried out qRT-PCR to test whether raised levels of PAX6 protein lowered the
expression of Pax6 mRNA. We found significantly reduced levels of mRNA for mouse
Pax6 in the telencephalon of PAX77+ E14.5 embryos, to one-third of wild-type levels
(Student’s t-test, P<0.03; n=3 embryos of each genotype), indicating that Pax6 negatively
regulates its own mRNA production and/or stability.
Pax6 overexpression alters cortical progenitor proliferation at late stages of
corticogenesis
Previous studies have shown that Pax6 is important in regulating cortical progenitor
proliferation and for promoting neurogenesis (Estivill-Torrus et al., 2002; Heins et al.,
2002). First, we tested whether overexpression of Pax6 has an effect on cortical-cell
proliferation. The proliferative zone of the neocortex contains two populations of
progenitors: apical progenitors (APs) undergo mitosis at the ventricular surface and express
high levels of Pax6; and basal progenitors (BPs) are derived from APs and divide in the
SVZ and basal VZ. Pax6 is downregulated during the transition from AP to BP (Englund et
al., 2005). BrdU was used to label cortical progenitors in S-phase of the cell cycle (Fig.
3D,E,G,H), and phosphorylated histone H3 was used as a marker of mitotic progenitors
(Fig. 3J,K). We determined the proportion of cells in S-phase (pScells) in the VZ along the
cortex of PAX77+ and wild-type embryos at E12.5, early in corticogenesis, and were unable
to detect any significant difference (Fig. 3A-F). We then determined the pScells and the
density of cells undergoing mitosis (dMcells) along the cortex of wild-type and PAX77+
embryos at E15.5, a late stage of corticogenesis. We found a significant reduction of the
pScells (Fig. 3G-I) and the dMcells (Fig. 3J-L) among APs in the rostral and central cortex of
PAX77+ embryos compared to wild type (Student’s t-test, P<0.05). No significant difference
was detected in the caudal cortex. Thus, Pax6 overexpression alters the proliferation of
rostral and central APs at late stages of corticogenesis, whereas early progenitors seem
unaffected. We did not find any significant alteration of pScells and dMcells among BPs in the
rostral, central and caudal cortex of PAX77+ embryos compared to wild type (data not
shown).
We tested whether overexpression of Pax6 causes an increase in neurogenesis by analyzing
the expression of the neuronal marker β-tubulin III in the cortex of wild-type and PAX77
embryos using immunohistochemistry and flow cytometry. We found no difference in the
proportions of β-tubulin III-expressing cells in PAX77 embryos compared to wild type (see
Fig. S2 in the supplementary material).
Manuel et al. Page 6
Development. Author manuscript; available in PMC 2008 May 16.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Effects of overexpression of Pax6 on late cortical progenitors are cell autonomous
In PAX77 mice, Pax6 levels are increased at all of its sites of expression, and so a late-onset
cortical defect might arise as a secondary consequence of defects elsewhere (e.g. PAX77
mice are microphthalmic and may have other as yet undetected extra-cortical abnormalities).
We tested whether the defects detected in mutants reflect a requirement for a correct level of
Pax6 within cortical progenitors themselves rather than in their environment. To
discriminate between these two possibilities, we analyzed foetal chimeras in which the
mutant cells have the potential to interact with wild-type cells so that any defects that they
retain are therefore more likely to be cell autonomous.
Embryos derived from a wild type×PAX77+ cross were aggregated to wild-type embryos,
carrying the Tg transgene as a marker, to produce control chimeras [wild-type;Tg−↔wild-
type;Tg+] or mutant chimeras [PAX77+;Tg−↔wild-type;Tg+]. Cells derived from the wild-
type embryo could be identified, after DNA in situ hybridization against Tg, by the presence
of a brown spot in the nucleus (Fig. 4A,B). The global percentage of cells derived from each
of the two embryos used to generate each chimera was estimated by quantitative analysis of
GPI1 isozyme composition of the limbs (West and Flockhart, 1994), with the percentage of
the GPI1A isozyme representing the contribution of cells derived from the wild-
type×PAX77+ cross.
We analyzed three control and four mutant chimeras at E16.5 and determined the percentage
of Tg− cells in the proliferative zones (VZ and SVZ), the intermediate zone (IZ) and the
cortical plate (CP) at rostral, central and caudal positions of each chimeric cortex. For each
chimera, the observed contribution of Tg− cells to each cortical region (obsTg−) was
compared to the expected contribution of Tg− cells (expTg−) given by the percentage of
GPI1A for that chimera. The mean ratio obsTg−:expTg− in the different cortical regions of
the control chimeras was always slightly greater than 1 (between 1.08 and 1.23, Fig. 4C-E),
reflecting the fact that the brown spot identifying Tg+ cells was not always present in the
plane of section analyzed, and the number of Tg− cells was therefore slightly overestimated.
This applied equally to control and mutant chimeras. Our results showed that the Tg− cells
in the mutant chimeras were significantly under-represented in the proliferative zones of the
rostral (Student’s t-test, P<0.01), central (P<0.05) and caudal (P<0.05) cortex compared with
the control chimeras (Fig. 4C). The Tg− cells in the mutant chimeras were also significantly
under-represented in the IZ of the rostral cortex (Student’s t-test, P<0.05) compared with
control chimeras (Fig. 4D). We did not detect any difference in the contribution of Tg− cells
to the cortical plate between mutant and control chimeras (Fig. 4E), consistent with there
having been no earlier defect in production of postmitotic cells. Overall, these results
indicate that, late in corticogenesis, cortical progenitors must express normal levels of Pax6
to contribute normally to the proliferative zones of the cortex.
We tested whether the under-representation of Pax6 overexpressing cells in the cortical
proliferative zones of chimeras was due to a cell-autonomous proliferation defect using
phosphorylated histone H3 as a marker of mitotic cells (Fig. 4F,G). We compared the
average proportion of Tg+ and Tg− cells in M-phase (pMTg+ and pMTg−, respectively) in the
VZ of the rostral cortex of mutant chimeras to the average proportion of cells in M-Phase
(pMcells) in the corresponding region of wild-type embryos. The average proportion of
mutant cells in M-phase (pMTg−) in chimeras (0.0123±0.0044 s.e.m., n=3) was significantly
lower than pMcells in wild-type embryos (Student’s t-test, P<0.03), indicating that correct
levels of Pax6 are required cell-autonomously in order to enable late cortical progenitors to
proliferate normally. We found that pMTg+ in mutant chimeras (0.0243±0.003 s.e.m., n=3)
was not significantly different from pMcells in wild-type embryos (0.0242±0.003 s.e.m.,
n=3), indicating that the presence of Pax6-overexpressing cells does not affect the
proliferation of wild-type cortical progenitors in mutant chimeras.
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Pax6 overexpression decreases the thickness of superficial cortical layers
The formation of superficial cortical layers occurs during late stages of corticogenesis (Caric
et al., 1997). We tested whether the defect in late cortical progenitor proliferation observed
in PAX77 embryos results in postnatal lamination defects. We compared the thickness of
deep (V and VI) and superficial (II-IV combined) cortical layers and of the marginal zone
(future layer I) in PAX77+ and wild-type brains at P7 (Fig. 5). The thickness of superficial
layers II-IV was significantly decreased in the rostral and central PAX77 cortex compared to
the wild-type cortex (Student’s t-test, P<0.01, n=3 brains of each genotype; Fig. 5C,D). The
thickness of deep cortical layers and that of layer I are not significantly altered in the PAX77
cortex. This is consistent with the late cortical progenitor proliferation defects observed in
PAX77 embryos.
Cortical arealization is largely unaffected by Pax6 overexpression
Previous work has suggested that Pax6 plays a crucial role in cortical arealization by
conferring rostro-lateral identities to cortical progenitors (Bishop et al., 2000; Bishop et al.,
2002; Muzio et al., 2002). The arealization of the neocortex is altered in Pax6−/− mice:
caudo-medial areas expand while rostro-lateral areas shrink. Moreover, expression of the
gene encoding the transcription factor Emx2, which confers caudo-medial identities, is
upregulated, suggesting that Pax6 downregulates Emx2 (Muzio et al., 2002). Accordingly,
we predicted that the overexpression of Pax6 would have an opposite effect on cortical
regionalization (i.e. the downregulation of Emx2 and a caudo-medial shift of rostro-lateral
areas at the expense of caudo-medial regions) (Fig. 6). To address the issue of how the
observed overexpression of Pax6 in the brains of PAX77 mice [1.5- to 2-fold and 3-fold for
Pax6 and Pax6(5a), respectively; Fig. 1] would be expected to impact cortical
regionalization, we measured the steepness of the cortical Pax6 gradient by quantitative
comparison of fluorescent Pax6 immunoreactivity between rostral and caudal cortical poles
of each of a series of sagittal sections (Materials and methods). The fluorescence intensity
was used as an indication of relative Pax6 expression levels. We found that the average ratio
between rostral and caudal Pax6 levels is 3.37 (±0.26 s.e.m., n=4) in the wild-type cortex
and 4.16 (±0.4 s.e.m., n=4) in the PAX77+ cortex (not significantly different, Student’s t-
test). As shown in Fig. 6A, this indicates that the overall steepness of the Pax6 gradient is
increased in the cortex of PAX77 embryos and the increase of Pax6 levels observed in the
brains of PAX77 transgenic embryos would be expected to displace anterior cortical regions
that normally express the highest levels of Pax6 to the posterior pole of the cortex.
To search for defects in cortical arealization in PAX77 mice, we first analyzed the
expression of Emx2, ephrin B2 and Id2, because their expression is normally restricted or
graded across the developing cortex of embryos (Bishop et al., 2000; Bishop et al., 2002;
Mallamaci et al., 1998; Muzio et al., 2002; Rubenstein et al., 1999). Emx2 is normally
expressed in a caudo-medialhigh to rostro-laterallow gradient in the embryonic cortex and this
gradient is conserved in PAX77+ (and PAX77+/+, data not shown) cortex at E12.5 with no
obvious difference in the intensity of label between the different genotypes (Fig. 7A,B). In
wild-type embryos at E16.5, Ephrin B2 is strongly expressed in a caudal domain of the
neocortex (up to the arrowhead in Fig. 7C). This caudal domain of strong expression of
Ephrin B2 is present in the cortex of PAX77+ (and PAX77+/+, data not shown) embryos and
does not appear contracted (Fig. 7D). In wild-type embryos at E18.5, Id2 is strongly
expressed in a rostral domain in layers 2 and 3 of the neocortex (Fig. 7E, arrow marks the
limit of this domain) and in a caudal domain in layer 5 (Fig. 7E, white arrowhead marks the
boundary of this domain). These patterns were not altered in PAX77+ (data not shown) nor
in PAX77+/+ embryos (Fig. 7F).
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Cortical areas are also characterized by the specific connections they establish with the
thalamus. The somatosensory and visual cortical areas normally establish axonal connexions
with the thalamic ventro-posterior geniculate (VP) and dorsal lateral geniculate (dLG),
respectively. We examined the organization of thalamocortical projections by injecting
fluorescent carbocyanine dyes (DiA and DiI) into visual and somatosensory cortical areas at
E17.5 (see Fig. S3A in the supplementary material). Neither PAX77+ (see Fig. S3C in the
supplementary material) nor PAX77+/+ (data not shown) embryos showed any consistent
differences in projections from that of wild type (see Fig. S3B in the supplementary
material) and in neither wild-type nor mutant mice did DiA at the caudal pole back label
neurons in the VP.
As an additional assay to analyze cortical regionalization in PAX77 mice, we used
serotonin-transporter immunostaining on tangential sections through flattened cortices of P7
wild-type and PAX77+/+ mice to reveal the primary somatosensory area (S1), visual area
(V1) and auditory area (A1) (Fig. 8A). We analyzed the size and position of the postero-
medial barrel subfield (PMBSF) - the representation of large facial whiskers in the primary
somatosensory area. We arbitrarily chose a barrel in the centre of the PMBSF, barrel c4, and
determined the ratio between the distance from this barrel to the rostral pole of the cortex
(R) and the total length of the cortex (T) (Fig. 8B). This rostral ratio was unchanged in the
cortex of PAX77 mice compared to wild type (Fig. 8B). The ratio between the distance of
barrel c4 to the caudal pole of the cortex (C) and the total length of the cortex was also
unaltered in PAX77 mice compared to wild type (Fig. 8C). We did find, however, that the
area of PMBSF relative to the total cortical area was reduced in the PAX77 cortex (Fig. 8D).
Thus, although there is no evidence that the overexpression of Pax6 results in a caudal shift
of the somatosensory area, it does reduce its area.
DISCUSSION
Our results show that the Pax6 gene negatively autoregulates its expression, that increased
levels of Pax6 protein cause cell-autonomous proliferative defects of the progenitors that
generate the superficial cortical layers and that Pax6 overexpression has surprisingly little
effect on cortical arealization. The transgenic model used to make these findings has several
major advantages. First, Pax6 levels are not raised excessively, but remain close to
physiological levels. Second, Pax6 is not ectopically expressed at sites where Pax6 is not
normally found, which would severely complicate the interpretation of abnormalities. Third,
the Pax6 protein produced by the transgene has been proven to be functional by genetic
complementation (Schedl et al., 1996).
Negative autoregulation of Pax6
Negative feedback is an important component of many stable systems, both biological and
non-biological: results from mathematical models and engineered gene circuits have
indicated that genes regulated by negative feedback show more stable expression than genes
that are unregulated (Hasty et al., 2002). Our identification of negative feedback in the
regulation of Pax6 expression in the developing brain highlights the probable importance of
maintaining appropriate levels of expression in the face of rapid intra- and extra-cellular
changes as embryos grow in size and complexity.
Our evidence for negative autoregulation of an intact locus in vivo comes from the finding
that GFP production from the Y1123 transgene, which reports faithfully the sites and levels
of activation of Pax6 (Kleinjan et al., 2006; Tyas et al., 2006), is upregulated on a Pax6−/−
background, where no endogenous Pax6 or Pax6(5a) protein is present (so freeing reporter
expression from regulation), and is reduced in PAX77 embryos in which Pax6 levels are
increased. Furthermore, we show that mouse Pax6 mRNA levels are reduced in mice that
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overexpress PAX6. This finding complements nicely previous studies reporting an increased
signal from in situ hybridizations for Pax6 mRNA in the telencephalon of Pax6−/− mutants
(Muzio et al., 2002) and increased expression of Pax6 in Pax6(5a)-/- mutants (Haubst et al.,
2004).
Despite negative feedback, Pax6 protein levels are elevated in PAX77 embryos; thus,
negative autoregulation is not able to overcome the effects of introducing five to seven
additional copies of the PAX6 locus in PAX77 mice. We found evidence that it constrains
the elevation of Pax6 levels in these mice. Western blots showed that absolute levels of Pax6
proteins are increased in the brain of PAX77+ embryos by approximately 1.5- to 3-fold.
Because PAX77+ mice contain five to seven extra copies of the gene (seven to nine copies
in total, as opposed to two), a slightly larger (3.5- to 4.5-fold) increase in protein levels
might have been predicted if each extra copy were functioning at a wild-type level. That
they are not is demonstrated by the reduction in expression from the Y1123 transgene on a
PAX77 background, which is roughly halved (Fig. 2).
These findings indicate that a negative-feedback mechanism is in place to stabilize Pax6
protein levels. Previous in vitro studies have shown that Pax6 proteins can bind to isolated
Pax6-promoter sequences, but that this results in activation of transcription (Aota et al.,
2003; Okladnova et al., 1998; Plaza et al., 1993; Plaza et al., 1995). Further evidence for
such activation comes from in vivo studies showing that, in some tissues (e.g. lens and
olfactory placodes, but not in cortex), Pax6 protein is required for transcription of the Pax6
gene (Aota et al., 2003; Grindley et al., 1995; Kim and Lauderdale, 2006; Kleinjan et al.,
2004). The mechanisms regulating the levels of expression of Pax6 are likely to be complex.
Our findings implicate negative autoregulation, be it direct or indirect, as a potent stabilizing
component in vivo.
Pax6 overexpression affects late cortical progenitor proliferation cell autonomously
We showed that controlled overexpression of Pax6 in vivo specifically affects the
proliferation of late cortical progenitors. This effect is strongest in rostral and central parts of
the cortex, where levels of Pax6 are highest. At E15.5, there are significant reductions in the
proportions of progenitor cells in S-phase and in their densities in M-phase both rostrally
and centrally; reductions are slightly greater rostrally. In E16.5 chimeras, there are
significant reductions in the numbers of mutant cells in rostral and central proliferative
layers; again, the reduction is slightly larger rostrally. In addition, the proportion of mutant
cortical progenitors in M-phase in the rostral cortex of the chimeras is lower than normal.
Consistent with these findings, superficial cortical layers II-IV, which arise mainly from
E15.5 onwards (Gillies and Price, 1993), are significantly thinner in the rostral and central
cortex of postnatal Pax6-overexpressing mice. Our in vivo findings complement a previous
study reporting that overexpression of Pax6 in vitro by viral transduction of dissociated
cortical cells at E14.5 results in an early exit from the cell cycle (Heins et al., 2002).
In E15.5 caudal cortex, where Pax6 levels are lowest, there are no differences in the
proportions of progenitor cells in S-phase and their densities in M-phase between PAX77
and wild-type mice. In the caudal cortex of E16.5 chimeras, however, the numbers of mutant
cells in the proliferative layers are significantly reduced, although the extent of the reduction
is smaller than in central and rostral regions. A possible explanation for these regional
differences is that the rostral cortex is more advanced than the caudal cortex at each
embryonic age (Bayer and Altman, 1991) and so the emergence of defects in the caudal
proliferative layers is delayed.
The emergence of defects occurring earliest in the rostral proliferative layers can explain
why defects of mutant cell numbers are restricted to specifically the rostral IZ of E16.5
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chimeras (Fig. 4D). These defects have not translated into reductions in mutant cell numbers
in the cortical plate by E16.5 (although there was a hint that a defect might be emerging in
the rostral cortical plate: Fig. 4E). They are, however, translated into defects of superficial-
layer thickness by P7, although we only observed significant reductions rostrally and
centrally. Because P7 is after the time at which migration of postmitotic neurons into the
cortex is complete both rostrally and caudally, the most likely explanation for the lack of
significant thinning caudally is that proliferation is affected less severely here, where Pax6 is
expressed at its lowest levels. Overall, our findings indicate that the level of Pax6 within
cortical progenitors becomes important in the regulation of their proliferation and hence in
the production of cortical layers.
Overexpression of Pax6 has little effect on cortical regionalization
Previous studies have suggested that Pax6 plays an important role in regulating cortical
regionalization by promoting rostro-lateral identities and repressing the expression of Emx2,
which confers caudo-medial identities (Bishop et al., 2000; Bishop et al., 2002; Muzio et al.,
2002; Muzio and Mallamaci, 2003). We predicted that an 1.5- to 3-fold overexpression of
Pax6 in the cortex would result in a downregulation of Emx2, such that caudal levels would
decrease to the very low levels normally found rostrally, and in a caudal shift of rostral areas
(Fig. 6). Unexpectedly, we found unaltered expression of Emx2 in the cortex of PAX77
embryos. The analysis of the expression of cortical markers, the topography of
thalamocortical connections and the position of the barrel field did not reveal any difference
between wild-type and PAX77 mice, suggesting that cortical regionalization is largely
unaffected by Pax6 overexpression. The only defect we observed is a reduction in the size of
PMBSF in PAX77 mice.
Previous studies have shown that the loss of Pax6 results in the upregulation of Emx2
expression (Muzio et al., 2002). One possibility to explain both this previous finding and our
new result is that Pax6 is needed to permit the repression of Emx2, but that its level of
expression does not determine the level of Emx2 expression. Existing evidence indicates
that the loss of Emx2 and overexpression of Emx2 in vivo shift cortical areas either caudally
or rostrally, respectively (Bishop et al., 2000; Hamasaki et al., 2004; Muzio et al., 2002). It
seems likely that Emx2 plays a dominant role in determining cortical arealization, whereas
Pax6 might have little or no direct role. Increased expression of Pax6 might not affect
arealization because it has little, if any, effect on Emx2 levels. Loss of Pax6 might indirectly
result in a rostral shift of cortical areas (Bishop et al., 2000; Muzio et al., 2002) as
consequence of the upregulation of Emx2. However, there are other ways in which the loss
of Pax6 might indirectly affect cortical arealization. The reduction of rostro-lateral cortical
areas in Pax6−/− embryos could be a consequence of the absence of olfactory placodes,
which emerge at E9.5 and are a region of mesenchymal-epithelial induction orchestrating
regional differentiation and pathway formation in the forebrain (Anchan et al., 1997; Balmer
and LaMantia, 2005; LaMantia, 1999; LaMantia et al., 2000; LaMantia et al., 1993).
Olfactory placodes fail to form in Pax6−/− embryos (Hogan et al., 1986) and the consequent
loss of signalling molecules might influence the development and regionalization of the
cortex. The olfactory placodes form normally in PAX77 mice (see Fig. S4 in the
supplementary material), which might explain the absence of cortical regionalization
defects.
On the other hand, we can not altogether exclude the possibility that increasing cortical Pax6
levels does have some effect on cortical arealization. The reduction in the size of the
primary somatosensory area in PAX77 mice could reflect the opposing effects of an
upregulated Pax6 gradient and an unaffected Emx2 gradient compressing the somatosensory
cortex between them, or might result from the increased steepness of the Pax6 gradient. It is
also possible, however, that the reduction in size of the somatosensory cortex in PAX77
Manuel et al. Page 11
Development. Author manuscript; available in PMC 2008 May 16.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
mice is a consequence of defects in the development of cortical layers II-IV, as discussed
above.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
We thank Simon Saule for the anti-Pax6 antibody; Georgio Corte for the Emx2 antibody; and Dennis O’Leary for
the Id2 in situ probe. We thank Peter Kind and Mark Barnett for advice and technical help with PMBSF labelling
and measurements; Mark Barnett for help with qRT-PCR; and Judy Fantes for help with FISH genotyping. We
thank Jean Flockhart, Duncan McNeil and Linda Wilson for technical assistance. Research in the authors’
laboratory is supported by the Wellcome Trust, the MRC and the BBSRC. M.M. was supported by postdoctoral
fellowships from the Association pour la Recherche sur le Cancer (ARC) and the EMBO.
References
Anchan RM, Drake DP, Haines CF, Gerwe EA, LaMantia AS. Disruption of local retinoid-mediated
gene expression accompanies abnormal development in the mammalian olfactory pathway. J.
Comp. Neurol. 1997; 379:171–184. [PubMed: 9050783]
Aota S, Nakajima N, Sakamoto R, Watanabe S, Ibaraki N, Okazaki K. Pax6 autoregulation mediated
by direct interaction of Pax6 protein with the head surface ectoderm-specific enhancer of the mouse
Pax6 gene. Dev. Biol. 2003; 257:1–13. [PubMed: 12710953]
Balmer CW, Lamantia AS. Noses and neurons: Induction, morphogenesis, and neuronal differentiation
in the peripheral olfactory pathway. Dev. Dyn. 2005; 234:464–481. [PubMed: 16193510]
Bayer SA, Altman J. Development of the endopiriform nucleus and the claustrum in the rat brain.
Neuroscience. 1991; 45:391–412. [PubMed: 1762685]
Bishop KM, Goudreau G, O’Leary DD. Regulation of area identity in the mammalian neocortex by
Emx2 and Pax6. Science. 2000; 288:344–349. [PubMed: 10764649]
Bishop KM, Rubenstein JL, O’Leary DD. Distinct actions of Emx1, Emx2, and Pax6 in regulating the
specification of areas in the developing neocortex. J. Neurosci. 2002; 22:7627–7638. [PubMed:
12196586]
Caric D, Gooday D, Hill RE, McConnell SK, Price DJ. Determination of the migratory capacity of
embryonic cortical cells lacking the transcription factor Pax-6. Development. 1997; 124:5087–5096.
[PubMed: 9362466]
Carriere C, Plaza S, Martin P, Quatannens B, Bailly M, Stehelin D, Saule S. Characterization of quail
Pax-6 (Pax-QNR) proteins expressed in the neuroretina. Mol. Cell. Biol. 1993; 13:7257–7266.
[PubMed: 8246948]
Englund C, Fink A, Lau C, Pham D, Daza RA, Bulfone A, Kowalczyk T, Hevner RF. Pax6, Tbr2, and
Tbr1 are expressed sequentially by radial glia, intermediate progenitor cells, and postmitotic
neurons in developing neocortex. J. Neurosci. 2005; 25:247–251. [PubMed: 15634788]
Estivill-Torrus G, Pearson H, van Heyningen V, Price DJ, Rashbass P. Pax6 is required to regulate the
cell cycle and the rate of progression from symmetrical to asymmetrical division in mammalian
cortical progenitors. Development. 2002; 129:455–466. [PubMed: 11807037]
Gillies K, Price DJ. Cell migration and subplate loss in explant cultures of murine cerebral cortex.
NeuroReport. 1993; 4:911–914. [PubMed: 8369482]
Grindley JC, Davidson DR, Hill RE. The role of Pax-6 in eye and nasal development. Development.
1995; 121:1433–1442. [PubMed: 7789273]
Grindley JC, Hargett LK, Hill RE, Ross A, Hogan BL. Disruption of PAX6 function in mice
homozygous for the Pax6Sey-1Neu mutation produces abnormalities in the early development and
regionalization of the diencephalon. Mech. Dev. 1997; 64:111–126. [PubMed: 9232602]
Hamasaki T, Leingartner A, Ringstedt T, O’Leary DD. EMX2 regulates sizes and positioning of the
primary sensory and motor areas in neocortex by direct specification of cortical progenitors.
Neuron. 2004; 43:359–372. [PubMed: 15294144]
Manuel et al. Page 12
Development. Author manuscript; available in PMC 2008 May 16.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Hasty J, McMillen D, Collins JJ. Engineered gene circuits. Nature. 2002; 420:224–230. [PubMed:
12432407]
Haubst N, Berger J, Radjendirane V, Graw J, Favor J, Saunders GF, Stoykova A, Gotz M. Molecular
dissection of Pax6 function: the specific roles of the paired domain and homeodomain in brain
development. Development. 2004; 131:6131–6140. [PubMed: 15548580]
Heins N, Malatesta P, Cecconi F, Nakafuku M, Tucker KL, Hack MA, Chapouton P, Barde YA, Gotz
M. Glial cells generate neurons: the role of the transcription factor Pax6. Nat. Neurosci. 2002;
5:308–315. [PubMed: 11896398]
Hill RE, Favor J, Hogan BL, Ton CC, Saunders GF, Hanson IM, Prosser J, Jordan T, Hastie ND, van
Heyningen V. Mouse small eye results from mutations in a paired-like homeobox-containing gene.
Nature. 1991; 354:522–525. [PubMed: 1684639]
Hogan BL, Horsburgh G, Cohen J, Hetherington CM, Fisher G, Lyon MF. Small eyes (Sey): a
homozygous lethal mutation on chromosome 2 which affects the differentiation of both lens and
nasal placodes in the mouse. J. Embryol. Exp. Morphol. 1986; 97:95–110. [PubMed: 3794606]
Keighren M, West JD. Analysis of cell ploidy in histological sections of mouse tissues by DNA-DNA
in situ hybridization with digoxigenin-labelled probes. Histochem. J. 1993; 25:30–44. [PubMed:
8432662]
Kerszberg M. Morphogen propagation and action: towards molecular models. Semin. Cell Dev. Biol.
1999; 10:297–302. [PubMed: 10441543]
Kim J, Lauderdale JD. Analysis of Pax6 expression using a BAC transgene reveals the presence of a
paired-less isoform of Pax6 in the eye and olfactory bulb. Dev. Biol. 2006; 292:486–505.
[PubMed: 16464444]
Kleinjan DA, Seawright A, Childs AJ, van Heyningen V. Conserved elements in Pax6 intron 7
involved in (auto)regulation and alternative transcription. Dev. Biol. 2004; 265:462–477.
[PubMed: 14732405]
Kleinjan DA, Seawright A, Mella S, Carr CB, Tyas DA, Simpson TI, Mason JO, Price DJ, van
Heyningen V. Long-range downstream enhancers are essential for Pax6 expression. Dev. Biol.
2006; 299:563–581. [PubMed: 17014839]
Kroll TT, O’Leary DD. Ventralized dorsal telencephalic progenitors in Pax6 mutant mice generate
GABA interneurons of a lateral ganglionic eminence fate. Proc. Natl. Acad. Sci. USA. 2005;
102:7374–7379. [PubMed: 15878992]
LaMantia AS. Forebrain induction, retinoic acid, and vulnerability to schizophrenia: insights from
molecular and genetic analysis in developing mice. Biol. Psychiatry. 1999; 46:19–30. [PubMed:
10394471]
LaMantia AS, Colbert MC, Linney E. Retinoic acid induction and regional differentiation prefigure
olfactory pathway formation in the mammalian forebrain. Neuron. 1993; 10:1035–1048. [PubMed:
8318228]
LaMantia AS, Bhasin N, Rhodes K, Heemskerk J. Mesenchymal/epithelial induction mediates
olfactory pathway formation. Neuron. 2000; 28:411–425. [PubMed: 11144352]
Lo CW. Localization of low abundance DNA sequences in tissue sections by in situ hybridization. J.
Cell Sci. 1986; 81:143–162. [PubMed: 3733894]
Lo CW, Coulling M, Kirby C. Tracking of mouse cell lineage using microinjected DNA sequences:
analyses using genomic Southern blotting and tissue-section in situ hybridizations. Differentiation.
1987; 35:37–44. [PubMed: 3428512]
Mallamaci A, Di Blas E, Briata P, Boncinelli E, Corte G. OTX2 homeoprotein in the developing
central nervous system and migratory cells of the olfactory area. Mech. Dev. 1996; 58:165–178.
[PubMed: 8887325]
Mallamaci A, Iannone R, Briata P, Pintonello L, Mercurio S, Boncinelli E, Corte G. EMX2 protein in
the developing mouse brain and olfactory area. Mech. Dev. 1998; 77:165–172. [PubMed:
9831645]
Martynoga B, Morrison H, Price DJ, Mason JO. Foxg1 is required for specification of ventral
telencephalon and region-specific regulation of dorsal telencephalic precursor proliferation and
apoptosis. Dev. Biol. 2005; 283:113–127. [PubMed: 15893304]
Manuel et al. Page 13
Development. Author manuscript; available in PMC 2008 May 16.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Mastick GS, Davis NM, Andrew GL, Easter SS Jr. Pax-6 functions in boundary formation and axon
guidance in the embryonic mouse forebrain. Development. 1997; 124:1985–1997. [PubMed:
9169845]
Muzio L, DiBenedetto B, Stoykova A, Boncinelli E, Gruss P, Mallamaci A. Emx2 and Pax6 control
regionalization of the pre-neuronogenic cortical primordium. Cereb. Cortex. 2002; 12:129–139.
[PubMed: 11739261]
Muzio L, Mallamaci A. Emx1, emx2 and pax6 in specification, regionalization and arealization of the
cerebral cortex. Cereb. Cortex. 2003; 13:641–647. [PubMed: 12764040]
Neumann C, Cohen S. Morphogens and pattern formation. BioEssays. 1997; 19:721–729. [PubMed:
9264255]
Okladnova O, Syagailo YV, Mossner R, Riederer P, Lesch KP. Regulation of PAX-6 gene
transcription: alternate promoter usage in human brain. Brain Res. Mol. Brain Res. 1998; 60:177–
192. [PubMed: 9757029]
Pinson J, Simpson TI, Mason JO, Price DJ. Positive autoregulation of the transcription factor Pax6 in
response to increased levels of either of its major isoforms, Pax6 or Pax6(5a), in cultured cells.
BMC Dev. Biol. 2006; 6:25. [PubMed: 16725027]
Plaza S, Dozier C, Saule S. Quail Pax-6 (Pax-QNR) encodes a transcription factor able to bind and
trans-activate its own promoter. Cell Growth Differ. 1993; 4:1041–1050. [PubMed: 8117618]
Plaza S, Dozier C, Turque N, Saule S. Quail Pax-6 (Pax-QNR) mRNAs are expressed from two
promoters used differentially during retina development and neuronal differentiation. Mol. Cell.
Biol. 1995; 15:3344–3353. [PubMed: 7760830]
Porteus MH, Brice AE, Bulfone A, Usdin TB, Ciaranello RD, Rubenstein JL. Isolation and
characterization of a library of cDNA clones that are preferentially expressed in the embryonic
telencephalon. Brain Res. Mol. Brain Res. 1992; 12:7–22. [PubMed: 1372074]
Pratt T, Vitalis T, Warren N, Edgar JM, Mason JO, Price DJ. A role for Pax6 in the normal
development of dorsal thalamus and its cortical connections. Development. 2000; 127:5167–5178.
[PubMed: 11060242]
Pratt T, Tian NM, Simpson TI, Mason JO, Price DJ. The winged helix transcription factor Foxg1
facilitates retinal ganglion cell axon crossing of the ventral midline in the mouse. Development.
2004; 131:3773–3784. [PubMed: 15240555]
Quinn JC, Molinek M, Martynoga BS, Zaki PA, Faedo A, Bulfone A, Hevner RF, West JD, Price DJ.
Pax6 controls cerebral cortical cell number by regulating exit from the cell cycle and specifies
cortical cell identity by a cell autonomous mechanism. Dev. Biol. 2006 doi:10.1016/j.physletb.
2003.10.071.
Rubenstein JL, Anderson S, Shi L, Miyashita-Lin E, Bulfone A, Hevner R. Genetic control of cortical
regionalization and connectivity. Cereb. Cortex. 1999; 9:524–532. [PubMed: 10498270]
Schedl A, Ross A, Lee M, Engelkamp D, Rashbass P, van Heyningen V, Hastie ND. Influence of
PAX6 gene dosage on development: overexpression causes severe eye abnormalities. Cell. 1996;
86:71–82. [PubMed: 8689689]
Schmahl W, Knoedlseder M, Favor J, Davidson D. Defects of neuronal migration and the pathogenesis
of cortical malformations are associated with Small eye (Sey) in the mouse, a point mutation at the
Pax-6-locus. Acta Neuropathol. 1993; 86:126–135. [PubMed: 8213068]
Schuurmans C, Armant O, Nieto M, Stenman JM, Britz O, Klenin N, Brown C, Langevin LM, Seibt J,
Tang H, et al. Sequential phases of cortical specification involve Neurogenin-dependent and -
independent pathways. EMBO J. 2004; 23:2892–2902. [PubMed: 15229646]
Stoykova A, Fritsch R, Walther C, Gruss P. Forebrain patterning defects in Small eye mutant mice.
Development. 1996; 122:3453–3465. [PubMed: 8951061]
Tabata T, Takei Y. Morphogens, their identification and regulation. Development. 2004; 131:703–712.
[PubMed: 14757636]
Tarabykin V, Stoykova A, Usman N, Gruss P. Cortical upper layer neurons derive from the
subventricular zone as indicated by Svet1 gene expression. Development. 2001; 128:1983–1993.
[PubMed: 11493521]
Manuel et al. Page 14
Development. Author manuscript; available in PMC 2008 May 16.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Tyas DA, Simpson TI, Carr CB, Kleinjan DA, van Heyningen V, Mason JO, Price DJ. Functional
conservation of Pax6 regulatory elements in humans and mice demonstrated with a novel
transgenic reporter mouse. BMC Dev. Biol. 2006; 6:21. [PubMed: 16674807]
Walther C, Gruss P. Pax-6, a murine paired box gene, is expressed in the developing CNS.
Development. 1991; 113:1435–1449. [PubMed: 1687460]
Warren N, Price DJ. Roles of Pax-6 in murine diencephalic development. Development. 1997;
124:1573–1582. [PubMed: 9108373]
Watson RF, Abdel-Majid RM, Barnett MW, Willis BS, Katsnelson A, Gillingwater TH, McKnight
GS, Kind PC, Neumann PE. Involvement of protein kinase A in patterning of the mouse
somatosensory cortex. J. Neurosci. 2006; 26:5393–5401. [PubMed: 16707791]
West JD, Flockhart JH. Genotypically unbalanced diploid<==>diploid foetal mouse chimaeras:
possible relevance to human confined mosaicism. Genet Res. 1994; 63:87–99. [PubMed: 8026741]
Yucel G, Small S. Morphogens: precise outputs from a variable gradient. Curr. Biol. 2006; 16:R29–
R31. [PubMed: 16401416]
Manuel et al. Page 15
Development. Author manuscript; available in PMC 2008 May 16.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Fig. 1. Pax6 protein levels are increased in PAX77 mice
(A) Western-blots of E12.5 wild-type, PAX77+ and PAX77+/+ telencephalic-protein extracts
with anti-Pax6 and anti-β-actin antibodies. (B) Quantitation of the two isoforms, 48 kDa
Pax6(5a) and 46 kDa Pax6, in E12.5 wild-type PAX77+ and PAX77+/+ telencephalons. For
each sample, the intensity of the Pax6 and Pax6(5a) bands was divided by the intensity of
the β-actin band to account for loading differences and values were calculated relative to the
mean value for wild-type Pax6, which was assigned a value of 1 (mean±s.e.m. are shown;
n=3 in all cases). Asterisks indicate statistically significant differences from wild type
(Student’s t-test, P<0.05). There was no significant difference between the levels of Pax6
and Pax6(5a) in PAX77+/+ and PAX77+ embryonic brains. (C-E) Immunohistochemistry on
sagittal sections through the cortex showing Pax6 expression in (C) wild-type (WT), (D)
PAX77+ and (E) PAX77+/+ E12.5 embryos. The rostro-lateralhigh to caudo-mediallow
gradient of Pax6 expression is conserved in the cortex of PAX77 mice. Scale bar: 200 μm.
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Fig. 2. Telencephalic expression of tau-GFP from Y1123 is regulated by differences in the levels
of Pax6 expression
Expression is shown in coronal sections from (A) Pax6+/+, (B) PAX77 and (C) Pax6−/−
E14.5 embryos. Scale bar: 200 μm. (D-H) Expression of tau-GFP quantified with flow
cytometry. (D-G) Examples of frequency histograms of cell number against GFP
fluorescence for samples of cells from the brains of (D) wild-type embryos and (E-G)
embryos containing Y1123 on (E) a wild-type background, (F) a Pax6−/− background and
(G) a PAX77 background. (H) Histogram showing the mean fluorescence of cells in gate B
(see D-G) from four to six embryos with each Y1123-containing genotype. All differences
are significant (P<0.001; Student’s t-test).
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Fig. 3. Pax6 overexpression affects late cortical progenitor proliferation
(A-C) Coronal sections at (A) rostral, (B) central and (C) caudal levels of the cortex (left
hemisphere shown) of an E12.5 wild-type embryo labeled with anti-BrdU (brown). Cell
counts were made in 100 μm-wide sampling boxes (red boxes). (D,E) Examples of anti-
BrdU labelling (brown) of coronal sections of the cortex of (D) a wild-type and (E) a
PAX77 embryo at E12.5. (F) The proportion of AP cells in S-phase along the cortex of
PAX77 embryos at E12.5 is not different from that of wild type. (G,H) Example of anti-
BrdU labeling (brown) of coronal sections of the cortex of (G) a wild-type and (H) a PAX77
embryo at E15.5. (I) The proportion of AP cells in S-phase in the rostral and central cortex
of PAX77 embryos at E15.5 is significantly decreased compared with wild type. (J,K)
Example of anti-phosphorylated histone H3 labeling (brown) of coronal sections of the
cortex of (J) a wild-type and (K) a PAX77 embryo at E15.5. (L) The density of AP cells in
M-phase in the rostral and central cortex of PAX77 embryos at E15.5 is significantly
decreased compared with wild type. All sections shown are counterstained with cresyl
violet. MZ, marginal zone; VZ, ventricular zone; SVZ, subventricular zone. Scale bars: 50
μm in A-E, 70 μm in G,H,J,K.
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Fig. 4. PAX77 cells are under-represented in the cortical proliferative layers of
PAX77+;Tg−↔wild-type;Tg+ chimeric embryos at E16.5
(A,B,F,G) Coronal sections through the cortex of a PAX77+;Tg−↔wild-type;Tg+ chimera at
E16.5. (A,B) Tg+ cells (marked with brown dots) and Tg− cells were counted in the
proliferative layers (VZ and SVZ), intermediate zone (IZ) and cortical plate (CP). (C-E)
Ratios of observed/expected contributions of Tg− (i.e. PAX77) cells in (C) VZ and SVZ, (D)
IZ and (E) CP. (C) PAX77;Tg− cells are significantly under-represented in the proliferative
layers along the chimeric cortex and (D) in the IZ of the rostral chimeric cortex. (F,G)
Example of Tg+ (arrow) and Tg− (arrowhead) apical progenitors in M-phase labelled with
anti-phosphorylated histone H3 (grey). Scale bars: 50 μm in A; 10 μm in B,F,G.
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Fig. 5. Pax6 overexpression affects the formation of superficial cortical layers
(A,B) Coronal sections through the cortex of (A) a wild-type and (B) a PAX77 mouse at P7,
stained with cresyl violet. Borders between adjacent cortical layers were identified based on
differences in cytoarchitecture. (C-E) Thickness of cortical layers I, II-IV (combined), V
and VI in the (C) rostral, (D) central and (E) caudal cortex of wild-type and PAX77 mice at
P7. The thickness of layers II-IV is significantly decreased in the rostral and central cortex
of PAX77 mice compared with wild type. Scale bar: 300 μm.
Manuel et al. Page 20
Development. Author manuscript; available in PMC 2008 May 16.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Fig. 6. Predicted shifts in the cortex of PAX77 mice
(A) Pax6 levels are about three times higher in the anterior cortex than in the posterior
cortex. In PAX77 mice, Pax6 expression is still graded, but is increased by 1.5- to 3-fold
(shown here as an average of approximately 2-fold). Thus, in PAX77 embryos, cells in
posterior regions of the cortex express levels of Pax6 that are normally found in anterior
regions. (B-D) Dorsal views of mouse neocortex. (B) In the wild-type, Pax6 is expressed in
a rostro-lateralhigh to caudo-mediallow gradient, while (C) Emx2 is expressed in an opposite
gradient. We predicted that the overexpression of Pax6 would result in a downregulation of
Emx2 expression and (D) in a caudal shift of rostral areas at the expense of caudal areas. M,
motor area; S, somatosensory area; V, visual area.
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Fig. 7. Pax6 overexpression does not alter the expression profile of cortical regionalization
markers
(A,B) Immunohistochemistry on sagittal sections through the cortex of (A) wild-type and
(B) PAX77+ E12.5 embryos showing the expression of Emx2. The gradient of Emx2
expression is conserved in the cortex of PAX77 mice and overall levels are not reduced.
(C,D) Immunohistochemistry on horizontal sections through the cortex of (C) wild-type and
(D) PAX77+ E16.5 embryos showing the expression of Ephrin B2 in the right hemisphere.
In the wild-type embryo, Ephrin B2 is strongly expressed in a caudal domain (arrowhead
shows the anterior limit of the Ephrin B2 caudal expression domain). This caudal domain is
present and does not appear contracted in the PAX77 cortex. (E,F) In situ hybridizations on
sagittal sections through the forebrain of (E) wild-type and (F) PAX77+/+ E18.5 embryos
showing the expression of Id2 mRNA. In the wild-type embryo, Id2 is strongly expressed in
layers 2 and 3 in an anterior domain (black arrow shows the posterior limit of this domain),
and in layer 5 in a caudal domain (white arrowhead shows the anterior limit of this domain).
The expression of Id2 appears unaltered in the PAX77 cortex. Scale bars: 200 μm in A-C;
0.5 mm in D-H.
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Fig. 8. The position of the postero-medial barrel subfield (PMBSF) is not shifted in PAX77
cortex but its size is reduced
(A) Tangential sections through one cortical hemisphere of P7 wild-type and PAX77+/+
mice stained with anti-serotonin transporter. The primary somatosensory (S1), auditory (A1)
and visual (V1) areas are revealed. (B) Measurements of the ratio between the distance of
barrel c4 from the rostral pole of the cortex (R, black arrow) and the total length of the
cortex (T, white arrow). No significant difference was found between wild-type and PAX77
mice (Student’s t-test, n=16). (C) Measurement of the ratio between the distance of barrel c4
from the caudal pole of the cortex (C, black arrow) and the total length of the cortex (T,
white arrow). No significant difference was found between wild-type and PAX77 mice
(Student’s t-test, n=16). (D) Measurement of the ratio between the area of the PMBSF (Pa)
and the total area of the cortex (Ca). **Area of PMBSF relative to the total cortical area was
significantly reduced in the PAX77 brain compared with wild type (Student’s t-test, P<0.01,
n=13 wild-type brains and 8 PAX77+/+ brains). Scale bars: 1 mm.
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